Sleep Disorders Trial, Recruiting (NCT06399939)

Sleep Disorders Trial, Recruiting NCT06399939 Sponsor: University of Massachusetts, Amherst Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06399939 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your baby is 9 months old at the time of enrollment
Your baby was born at a normal weight (between 5.5 and 10 lbs) and after a typical length pregnancy (between 36 and 41 weeks)
You are able and willing to come back for follow-up visits at 3 and 6 months from enrollment (for example, you do not have plans to move away from the area)

Who may not be able to join:

Your baby was born prematurely (before 36 weeks of pregnancy)
Your baby is currently receiving services for developmental delays
Your baby has a visual or movement-related disability
Your baby scores below a certain level on thinking and language assessments given at the first visit (confirm with trial site)
Your baby scores below a certain level on movement and motor skill assessments given at the first visit (confirm with trial site)
Your baby has traveled across more than one time zone within the 2 weeks before testing
Your baby has a fever or signs of a respiratory illness (such as a cold) at the time of testing
Your baby has a physical condition that would interfere with assessments, such as a vision or hearing impairment
Your baby has a history of a neurological condition, such as seizures, a brain tumor, or a stroke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06399939

Sponsor: University of Massachusetts, Amherst

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

More information: https://clinicaltrials.gov/study/NCT06399939

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your baby is 9 months old at the time of enrollment
Your baby was born at a normal weight (between 5.5 and 10 lbs) and after a typical length pregnancy (between 36 and 41 weeks)
You are able and willing to come back for follow-up visits at 3 and 6 months from enrollment (for example, you do not have plans to move away from the area)

Who may not be able to join:

Your baby was born prematurely (before 36 weeks of pregnancy)
Your baby is currently receiving services for developmental delays
Your baby has a visual or movement-related disability
Your baby scores below a certain level on thinking and language assessments given at the first visit (confirm with trial site)
Your baby scores below a certain level on movement and motor skill assessments given at the first visit (confirm with trial site)
Your baby has traveled across more than one time zone within the 2 weeks before testing
Your baby has a fever or signs of a respiratory illness (such as a cold) at the time of testing
Your baby has a physical condition that would interfere with assessments, such as a vision or hearing impairment
Your baby has a history of a neurological condition, such as seizures, a brain tumor, or a stroke

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Massachusetts, Amherst

Registry

ClinicalTrials.gov

Start date

1 September 2023

Est. completion

31 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Memory accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov